PETROC GROUP PRACTICE
THE SURGERY, TREKENNING ROAD, ST. COLUMB
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 25 | 34 | 73.5% | |
| HF 4 | 2011 | 36 | 46 | 78.3% | |
| HF 4 | 2012 | 45 | 53 | 84.9% | |
| HF 4 | 2013 | 43 | 55 | 78.2% | |
| HF004 | 2014 | 29 | 31 | 93.5% | |
| HF004 | 2015 | 29 | 33 | 87.9% | |
| HF004 | 2016 | 27 | 31 | 87.1% | |
| HF004 | 2017 | 28 | 32 | 87.5% | |
| HF004 | 2018 | 28 | 32 | 87.5% | |
| HF004 | 2019 | 30 | 34 | 88.2% | |
| HF004 | 2020 | 41 | 44 | 93.2% | |
| HF006 | 2021 | 45 | 48 | 93.8% | |
| HF006 | 2022 | 45 | 47 | 95.7% | |
| HF006 | 2023 | 52 | 52 | 100.0% |
